Solventum Corp SOLV

NYSE US Health Care

$89.32 ▼ -0.25% ($-0.22)

Index member: S&P 500

Open $89.17

Prev Close $89.54

Day Range $88.29 – $89.89

52W Range $62.38 – $94.16

Market Cap $15.24B

P/E (TTM) 10.62

Beta 0.73

EPS (TTM) $8.19

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2024-03-26
Shares Out.	173,170,000
Website	solventum.com/en-us/home/ ↗
Phone	16517331110
Employees	20,000
Revenue	$2.21B
Gross Profit	$1.29B
Net Income	$93.0M
Free Cash Flow	-$118.0M
Total Assets	$14.24B
Total Liabilities	$9.44B
Equity	$4.80B

About Solventum Corp

In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.

Solventum Corp is a publicly traded company under the ticker symbol SOLV on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.